Transformation of normal human cells in the absence of telomerase activation

Cancer Cell

Volumn 2, Issue 5, 2002, Pages 401-413

  Seger, Yvette R ^a,b   García Cao, Marta ^c   Piccinin, Sara ^d   Lo Cunsolo, Crocifissa ^e   Doglioni, Claudio ^e   Blasco, María A ^d   Hannon, Gregory J ^a   Maestro, Roberta ^d  

^a Watson School of Biological Sciences   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^e Belluno City Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; E1A PROTEIN; PROTEIN MDM2; RAS PROTEIN; TELOMERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TELOMERE; VIRUS EXPRESSION; ANIMAL; CELL CULTURE; CELL TRANSPLANTATION; CHROMOSOME ABERRATION; COMPARATIVE STUDY; FIBROBLAST; GENETICS; METABOLISM; NUDE MOUSE; PHYSIOLOGY; RETROVIRUS; VIRUS CELL TRANSFORMATION;

ADENOVIRIDAE; ANIMALIA; RODENTIA;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CELL TRANSPLANTATION; CELLS, CULTURED; CHROMOSOME ABERRATIONS; ENZYME ACTIVATION; FIBROBLASTS; HUMANS; MICE; MICE, NUDE; RETROVIRIDAE; TELOMERASE; TELOMERE;

EID: 19044390359     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00183-6     Document Type: Article

References (70)

1. Albanell, J., Lonardo, F., Rusch, V., Engelhardt, M., Langenfeld, J., Han, W., Klimstra, D., Venkatraman, E., Moore, M.A., and Dmitrovsky, E. (1997). High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. J. Natl. Cancer Inst. 89, 1609-1615.
2. Barbacid, M. (1987). Ras genes. Annu. Rev. Biochem. 56, 779-827.
3. Barbeau, D., Charbonneau, R., Whalen, S.G., Bayley, S.T., and Branton, P.E. (1994). Functional interactions within adenovirus E1A protein complexes. Oncogene 9, 359-373.
4. Blasco, M.A., Lee, H.W., Rizen, M., Hanahan, D., DePinho, R., and Greider, C.W. (1997a). Mouse models for the study of telomerase. Ciba Found. Symp. 211, 160-176.
5. Blasco, M.A., Lee, H.W., Hande, M.P., Samper, E., Lansdorp, P.M., DePinho, R.A., and Greider, C.W. (1997b). Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34.
6. Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C., Morin, G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S., and Wright, W.E. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352.
7. Boyd, J.M., Subramanian, T., Schaeper, U., La Regina, M., Bayley, S., and Chinnadurai, D. (1993). A region in the C-terminus of adenovirus 2/5 E1A protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis, and metastasis. EMBO J. 12, 469-478.
8. Bryan, T.M., and Reddel, R.R. (1997). Telomere dynamics and telomerase activity in in vitro immortalised cells. Eur. J. Cancer 33, 767-773.
9. Bryan, T.M., Englezou, A., Dalla-Pozza, L., Dunham, M.A., and Reddel, R.R. (1997). Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3, 1271-1274.
10. Chadeneau, C., Hay, K., Hirte, H.W., Gallinger, S., and Bacchetti, S. (1995). Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 55, 2533-2536.
11. Chin, L., Artandi, S.E., Shen, Q., Tam, A., Lee, S.L., Gottleib, G.J., Greider, C.W., and DePinho, R.A. (1999). p53-deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527-538.
12. Counter, C.M., Hahn, W.C., Wei, W., Caddle, S.D., Beijersbergen, R.L., Lansdorp, P.M., Sedivy, J.M., and Weinberg, R.A. (1998). Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl. Acad. Sci. USA 95, 14723-14728.
13. Debbas, M., and White, E. (1993). Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7, 546-554.
14. Dei Tos, A.P., Piccinin, S., Doglioni, C., Vukosavljevic, T., Mentzel, T., Boiocchi, M., and Fletcher, C.D. (1997). Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma. Am. J. Pathol. 151, 1531-1539.
15. de Stanchina, E., McCurrach, M.E., Zindy, F., Shieh, S.Y., Ferbeyre, G., Samuelson, A.V., Roussel, M.F., Sherr, C.J., and Lowe, S.W. (1998). E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12, 2434-2442.
16. Dorsman, J.C., Hagmeyer, B.M., Veenstra, J., Elfferich, N.N., Zantema, A., and Van Der Eb, A.J. (1995). The N-terminal region of the adenovirus type 5 E1A proteins can repress expression of cellular genes via two distinct but overlapping domains. J. Virol. 69, 2962-2967.
17. Dunham, M.A., Neumann, A.A., Fasching, C.L., and Reddel, R.R. (2000). Telomere maintenance by recombinantion in human cells. Nat. Genet. 26, 447-450.
18. Ebina, Y., Yamada, H., Fujino, T., Furuta, I., Sakuragi, N., Yamamoto, R., Katoh, M., Oshimura, M., and Fujimoto, S. (1999). Telomerase activity correlates with histo-pathological factors in uterine endometrial carcinoma. Int. J. Cancer 84, 529-532.
19. Elenbaas, B., Spirio, L., Koerner, F., Fleming, M.D., Zimonjic, D.B., Donaher, J.L., Popescu, N.C., Hahn, W.C., and Weinberg, R.A. (2001). Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15, 50-65.
20. Feuer, G., Stewart, S.A., Baird, S.M., Lee, F., Feuer, R., and Chen, I.S. (1995). Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses. J. Virol. 69, 1328-1333.
21. Fuchs, M., Gerber, J., Drapkin, R., Sif, S., Ikura, T., Ogryzko, V., Lane, W.S., Nakatani, Y., and Livingston, D.M. (2001). The p400 complex is an essential E1A transformation target. Cell 106, 297-307.
22. González-Suárez, E., Samper, E., Flores, J.M., and Blasco, M.A. (2000). Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat. Genet. 26, 114-117.
23. Goodman, R.H., and Smolik, S. (2000). CBP/p300 in cell growth, transformation, and development. Genes Dev. 14, 1553-1577.
24. Greenberg, R.A., Chin, L., Femino, A., Lee, K.H., Gottlieb, G.J., Singer, R.H., Greider, C.W., and DePinho, R.A. (1999). Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell 97, 515-525.
25. Hahn, W.C., Counter, C.M., Lundberg, A.S., Beijersbergen, R.L., Brooks, M.W., and Weinberg, R.A. (1999). Creation of human tumor cells with defined genetic elements. Nature 400, 464-468.
26. Hahn, W.C., Dessain, S.K., Brooks, M.W., King, J.E., Elenbaas, B., Sabatini, D.M., DeCaprio, J.A., and Weinberg, R.A. (2002). Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell. Biol. 22, 2111-2123.
27. Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57-70.
28. Hannon, G.J., Sun, P., Carnero, A., Xie, L.Y., Maestro, R., Conklin, D.S., and Beach, D. (1999). MaRX: an approach to genetics in mammalian cells. Science 283, 1129-1130.
29. Harlow, E., Whyte, P., Franza, B.R., Jr., and Schley, C. (1986). Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol. Cell. Biol. 6, 1579-1589.
30. Harlow, E., and Lane, D. (1999). Using Antibodies: A Laboratory Manual. (Cold Spring Harbor: Cold Spring Harbor Laboratory Press).
31. Harrington, E.A., Bennett, M.R., Fanindi, A., and Evan, G.I. (1994). c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13, 3286-3295.
32. Hermeking, H., and Eick, D. (1994). Mediation of c-Myc-induced apoptosis by p53. Science 265, 2091-2093.
33. Herrera, E., Samper, E., Martin-Caballero, J., Flores, J.M., Lee, H.W., and Blasco, M.A. (1999). Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 18, 2950-2960.
34. Herrera, E., Martinez, A.C., and Blasco, M.A. (2000). Impaired germinal center reaction in mice with short telomeres. EMBO J. 19, 472-481.
35. Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M.A., and Shay, J.W. (1995). Correlating telomerase activity levels with human neuroblastoma outcomes. Nat. Med. 1, 249-255.
36. Hoare, S.F., Bryce, L.A., Wisman, G.B., Burns, S., Going, J.J., van der Zee, A.G., and Keith, W.N. (2001). Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter. Cancer Res. 61, 27-32.
37. Imam, S.A., Kim, M.S., Anker, L., Datar, R.H., Law, R.E., and Taylor, C.R. (1997). Systematic determination of telomerase activity and telomere length during the progression of human breast cancer in cell culture models. Anticancer Res. 17, 4435-4441.
38. Kamijo, T., Zindy, F., Roussel, M.F., Quelle, D.E., Downing, J.R., Ashmun, R.A., Grosveld, G., and Sherr, C.J. (1997). Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649-659.
39. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L., and Shay, J.W. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
40. Land, H., Parada, L.F., and Weinberg, R.A. (1983). Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596-602.
41. Lee, H.W., Blasco, M.A., Gottliebb, G.J., Horner, J.W., 2nd, Greider, C.W., and DePinho, R.A. (1998). Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569-574.
42. Lin, A.W., Barradas, M., Stone, J.C., van Aelst, L., Serrano, M., and Lowe, S.W. (1998). Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12, 3008-3019.
43. Lowe, S.W., and Ruley, H.E. (1993). Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7, 535-545.
44. Lowe, S.W., Bodis, S., McClatchey, A., Remington, L., Ruley, H.E., Fisher, D.E., Housman, D.E., and Jacks, T. (1994). p53 status and the efficacy of cancer therapy in vivo. Science 266, 807-810.
45. McEachern, M.J., Krauskopf, A., and Blackburn, E.H. (2000). Telomeres and their control. Annu. Rev. Genet. 34, 331-358.
46. McIlrath, J., Bouffler, S.D., Samper, E., Cuthbert, A., Wojcik, A., Szumiel, I., Bryant, P.E., Riches, A.C., Thompson, A., Blasco, M.A., et al. (2001). Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res. 61, 912-915.
47. McMahon, S.B., Van Buskirk, H.A., Dugan, K.A., Copeland, T.D., and Cole, M.D. (1998). The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94, 363-374.
48. Meloni, A.R., Smith, E.J., and Nevins, J.R. (1999). A mechanism for Rb/p130-mediated transcription repression involving recruitment of the CtBP corepressor. Proc. Natl. Acad. Sci. USA 96, 9574-9579.
49. Meyerson, M., Counter, C.M., Eaton, E.N., Ellisen, L.W., Steiner, P., Caddle, S.D., Ziaugra, L., Beijersbergen, R.L., Davidoff, M.J., Liu, Q., et al. (1997). hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells during immortalization. Cell 90, 785-795.
50. Nanda, I., Schneider-Rasp, S., Winking, H., and Schmid, M. (1995). Loss of telomeric sites in the chromosomes of mus musculus domesticus (Rodentia: Muridae) during Robertsonian rearrangements. Chromosome Res. 3, 399-409.
51. O'Brien, W., Stenman, G., and Sager, R. (1986). Suppression of tumor growth by senescence in virally transformed human fibroblasts. Proc. Natl. Acad. Sci. USA 83, 8659-8663.
52. Paulovich, A.G., Toczyski, D.P., and Hartwell, L.H. (1997). When checkpoints fail. Cell 88, 315-322.
53. Rudolph, K.L., Millard, M., Bosenberg, M.W., and DePinho, R.A. (2001). Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet. 28, 155-159.
54. Ruley, H.E. (1983). Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304, 602-606.
55. Sager, R. (1991). Senescence as a mode of tumor suppression. Environ. Health Perspect. 93, 59-62.
56. Samper, E., Goytisolo, F.A., Slijepcevic, P., van Buul, P.P., and Blasco, M.A. (2000). Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep. 1, 244-252.
57. Samper, E., Goytisolo, F.A., Menissier-de Murcia, J., Gonzalez-Suarez, E., Cigudosa, J.C., de Murcia, G., and Blasco, M.A. (2001). Normal telomere length and chromosomal end capping in poly (ADP-ribose) polymerase-deficient mice and primary cells despite increased chromosomal instability. J. Cell Biol. 154, 49-60.
58. Samuelson, A.V., and Lowe, S.W. (1997). Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. Proc. Natl. Acad. Sci. USA 94, 12094-12099.
59. Sherr, C.J. (1996). Cancer cell cycles. Science 274, 1672-1677.
60. Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R.A. (1996). Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37.
61. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D.H., and Lowe, S.W. (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602.
62. Stevenson, M., and Volsky, D.J. (1986). Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes. Mol. Cell. Biol. 6, 3410-3417.
63. Tang, R., Cheng, A.J., Wang, J.Y., and Wang, T.C. (1998). Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis. Cancer Res. 58, 4052-4054.
64. Wang, H.H., Moran, E., and Yaciuk, P. (1995). E1A promotes association between p300 and pRb in multimeric complexes required for normal biological activity. J. Virol. 69, 7917-7924.
65. Wang, J., Xie, L.Y., Allan, S., Beach, D., and Hannon, G.J. (1998). Myc activates telomerase. Genes Dev. 12, 1769-1774.
66. Webb, C.P., Van Aelst, L., Wigler, M.H., and Woude, G.F. (1998). Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc. Natl. Acad. Sci. USA 95, 8773-8778.
67. Whyte, P., Buchkovich, K.J., Horowitz, J.M., Friend, S.H., Raybuck, M., Weinberg, R.A., and Harlow, E. (1988). Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334, 124-129.
68. Whyte, P., Williamson, N.M., and Harlow, E. (1989). Cellular targets for transformation by the adenovirus E1A proteins. Cell 56, 67-75.
69. Wright, W.E., Shay, J.W., and Piatyszek, M.A. (1995). Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity, and sensitivity. Nucleic Acids Res. 23, 3794-3795.
70. Yan, P., Coindre, J.M., Benhattar, J., Bosman, F.T., and Guillou, L. (1999). Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity. Cancer Res. 59, 3166-3170.